Education
About Us
Working with TipRanks
Follow Us
William Bertrand Insider Profile
4 Followers
William Bertrand, General Counsel at Infinity Pharmaceuticals, holds 986.35K shares in Adaptimmune Therapeutics (Ticker: ADAP), holds 290.71K shares in Ardelyx (Ticker: ARDX), holds 7.50K shares in Infinity Pharmaceuticals (Ticker: INFIQ). Most recently, William Bertrand Sold ― shares of Adaptimmune Therapeutics on Aug 29, 2025 for an estimated value of $2.07K.
William Bertrand Infinity Pharmaceuticals (INFIQ)General Counsel
Infinity Pharmaceuticals (INFIQ)
General Counsel
Ranked #69,108 out of 103,341 Corporate Insiders
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-13.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that William Bertrand holds in companies
Most Profitable Insider Trade
The most profitable trade made by William Bertrand
William Bertrand's Trading History
Infinity Pharmaceuticals
Oct 20, 2015
General Counsel
Uninformative Buy
―
―
Adaptimmune Therapeutics
Aug 29, 2025
COO
Informative Sell
2.07K
$40.44K
Salix
Apr 03, 2015
―
Uninformative Sell
513.64K
―
Ardelyx
Jun 23, 2025
Director
Uninformative Buy
―
$1.90M
Santarus
―
―
―
―
List of latest transactions for each holding click on a transaction to see William Bertrand's performance on stock
You May Also Like
William Bertrand insider profile FAQ
What is the percentage of profitable transactions made by William Bertrand?
The percentage of profitable transactions made by William Bertrand is 0%.
What is the average return per transaction made by William Bertrand?
The average return per transaction made by William Bertrand is -13.70%.
What stocks does William Bertrand hold?
William Bertrand holds: INFIQ, ADAP, SLXP, ARDX, SNTS stocks.
What was William Bertrand’s latest transaction?
William Bertrand latest transaction was an Informative Sell of $2.07K.
What was William Bertrand's most profitable transaction?
William Bertrand’s most profitable transaction was an Informative Sell of ADAP stock on August 29, 2025. The return on the trade was 0.00%.
What is William Bertrand's role in Infinity Pharmaceuticals?
William Bertrand's role in Infinity Pharmaceuticals is General Counsel.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.